These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3858828)
1. Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens. Tanaka T; Slamon DJ; Cline MJ Proc Natl Acad Sci U S A; 1985 May; 82(10):3400-4. PubMed ID: 3858828 [TBL] [Abstract][Full Text] [Related]
2. Antibodies specific for the polyoma virus middle-size tumor antigen. Walter G; Hutchinson MA; Hunter T; Eckhart W Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4882-6. PubMed ID: 6272281 [TBL] [Abstract][Full Text] [Related]
3. Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Walter G; Scheidtmann KH; Carbone A; Laudano AP; Doolittle RF Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5197-200. PubMed ID: 6254066 [TBL] [Abstract][Full Text] [Related]
4. Production of heterologous antibodies specific for murine B-cell leukemia (BCL1) immunoglobulin by immunization with synthetic peptides homologous to heavy chain hypervariable regions. Smith LJ; Maloy WL; Braylan RC; Wakeland EK Cancer Res; 1985 Dec; 45(12 Pt 1):6119-23. PubMed ID: 3933821 [TBL] [Abstract][Full Text] [Related]
5. Generation of rabbit antipeptide antibodies to HLA-class II antigens by the use of synthetic peptides. Chersi A; Morganti MC; Chillemi F; Houghten R; Cenciarelli C Clin Exp Immunol; 1988 Jul; 73(1):76-81. PubMed ID: 3168331 [TBL] [Abstract][Full Text] [Related]
6. Specificity of rabbit antibodies elicited by related synthetic peptides. Chersi A; Houghten RA; Chillemi F; Zito R; Centis D Z Naturforsch C J Biosci; 1986; 41(5-6):613-7. PubMed ID: 2944299 [TBL] [Abstract][Full Text] [Related]
7. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Dillner J; Sternås L; Kallin B; Alexander H; Ehlin-Henriksson B; Jörnvall H; Klein G; Lerner R Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4652-6. PubMed ID: 6205400 [TBL] [Abstract][Full Text] [Related]
8. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1. Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494 [TBL] [Abstract][Full Text] [Related]
9. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298 [TBL] [Abstract][Full Text] [Related]
10. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25. Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417 [TBL] [Abstract][Full Text] [Related]
11. Antisera to a synthetic peptide recognize native and denatured rat estrogen receptors. Furlow JD; Ahrens H; Mueller GC; Gorski J Endocrinology; 1990 Sep; 127(3):1028-32. PubMed ID: 2201530 [TBL] [Abstract][Full Text] [Related]
12. Antipeptide antibodies define the NH2-terminal structure of the pan-specific hemopoietin interleukin 3. Ziltener HJ; Clark-Lewis I; Fazekas de St Groth B; Hood LE; Kent SB; Schrader JW J Immunol; 1987 Feb; 138(4):1105-8. PubMed ID: 2433341 [TBL] [Abstract][Full Text] [Related]
14. Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients. Takahashi T; Irie RF; Morton DL; Hoon DS Cell Immunol; 1997 Jun; 178(2):162-71. PubMed ID: 9225007 [TBL] [Abstract][Full Text] [Related]
15. Functional domains of human interferon gamma probed with antipeptide antibodies. Lord SC; McMullen GL; Marzuki S; Cheetham BF Mol Immunol; 1989 Jul; 26(7):637-40. PubMed ID: 2506444 [TBL] [Abstract][Full Text] [Related]
16. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes. Tahara K; Takesako K; Sette A; Celis E; Kitano S; Akiyoshi T Clin Cancer Res; 1999 Aug; 5(8):2236-41. PubMed ID: 10473111 [TBL] [Abstract][Full Text] [Related]
17. Structural probing of human lutropin using antibodies raised against synthetic peptides constructed by classical and multiple antigen peptide system approaches. Troalen F; Razafindratsita A; Puisieux A; Voeltzel T; Bohuon C; Bellet D; Bidart JM Mol Immunol; 1990 Apr; 27(4):363-8. PubMed ID: 1694262 [TBL] [Abstract][Full Text] [Related]
18. Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12. Wong G; Arnheim N; Clark R; McCabe P; Innis M; Aldwin L; Nitecki D; McCormick F Cancer Res; 1986 Dec; 46(12 Pt 1):6029-33. PubMed ID: 3490906 [TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method. Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627 [TBL] [Abstract][Full Text] [Related]
20. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions. Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]